Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 181 - 210 of 459
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	AmBisome liposomal 50 mg infuusiokuiva-aine, dispersiota varten SPC 2024-06-10
PL	Resepti	Ambrisentan Accord 5 mg, 10 mg tabletti, kalvopäällysteinen SPC 2023-01-18
		European Medicines Agency's website: Ambrisentan Viatris (ent. Ambrisentan Mylan) - EMA: EPAR PI Finnish Swedish
PL	Resepti/itsehoito	Ambroxol ratiopharm 3 mg-ml, oraaliliuos SPC 2023-07-07
PL	Resepti/itsehoito	Ambroxol ratiopharm 6 mg-ml, oraaliliuos SPC 2023-07-07
PL	Resepti/itsehoito	Ambroxol ratiopharm 60 mg poretabletti SPC 2022-08-12
PL	Resepti	Amekrin 75 mg-1,5 ml konsentraatti ja liuotin välikonsentraatiksi infuusionestettä varten SPC 2021-03-25
		European Medicines Agency's website: Ameluz - EMA: EPAR PI Finnish Swedish
PL	Resepti	Amerscan Pentetate II Technetium Agent 20.6 mg valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2003-07-22
		European Medicines Agency's website: AMGEVITA - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Amglidia - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Amifampridine SERB - EMA: EPAR PI Finnish Swedish
PL	Resepti	Amikacin Macure 250 mg-ml injektioneste, liuos SPC 2023-04-28
PL	Resepti	Aminocont 225 mg depottabletti SPC 2023-03-29
PL	Resepti	Aminoplasmal 16 N-l infuusioneste, liuos SPC 2020-07-10
PL	Resepti	Amiodaron hameln 50 mg-ml injektio-infuusiokonsentraatti, liuosta varten SPC 2022-06-24
PL	Resepti	Amitrid 5 mg-50 mg, Amitrid mite 2.5 mg-25 mg tabletti SPC 2023-09-06
PL	Resepti	Amitrid 5 mg-50 mg, Amitrid mite 2.5 mg-25 mg tabletti SPC 2023-09-06
PL	Resepti	Amitriptylin Abcur 10 mg, 25 mg, 50 mg tabletti, kalvopäällysteinen SPC 2024-09-05
PL	Resepti	Amlobel 10 mg tabletti SPC 2008-03-26.doc
PL	Resepti	Amlobel 5 mg tabletti SPC 2008-03-26.doc
PL	Resepti	Amlodipin AbZ-pharma 10 mg tabletti SPC 2004-10-18
PL	Resepti	Amlodipin AbZ-pharma 5 mg tabletti SPC 2004-10-18
PL	Resepti	Amlodipin Accord 5 mg, 10 mg tabletti SPC 2022-06-27
PL	Resepti	Amlodipin Krka 5 mg, 10 mg tabletti SPC 2022-06-10
PL	Resepti	Amlodipin Orion 5 mg, 10 mg tabletti SPC 2022-06-21
PL	Resepti	Amlodipin Sandoz 5 mg, 10 mg tabletti SPC 2022-06-20
PL	Resepti	Amlodipin Taw Pharma 1 mg-ml oraalisuspensio SPC 2022-09-02
PL	Resepti	Amlodipin-Valsartan Krka 5 mg-320 mg, 10 mg-320 mg tabletti, kalvopäällysteinen SPC 2022-06-10
PL	Resepti	Amlodipin-Valsartan Krka 5 mg-80 mg, 5 mg-160 mg, 10 mg-160 mg tabletti, kalvopäällysteinen SPC 2022-06-10
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  |  Next 30   >